From Pharmaceuticalintelligence.com (as previously linked

New Post Public Reply Private Reply Replies (0) Message Board
patientgal
From Pharmaceuticalintelligence.com (as previously linked to by that brainiac, the popo, over yonder and here, too, I do believe):

" Overall purpose is to find a method to manipulate IDO for clinical applications, mainly the focus of this review is is cancer prevention and treatment.  The first study proving the connection between IDO and immune response came from, a very natural event, a protection of pregnancy in human. This led to discover that high IDO expression is a common factor in cancer tumors. Thus, attention promoted investigations on IDO’s role in various disease states, immune disorders, transplantation, inflammation, women health, mood disorders.  Many approaches, vaccines and adjuvants are underway to find new immunotherapies by combining the power of DCs in immune response regulation and specific direction of siRNA .  As a result, with this unique qualities of IDO, DCs and siRNA, we orchestrated a novel intervention for immunomodulation of IDO by inhibiting with small interference RNA, called siRNA-IDO-DCvax.  Proven that our DCvax created a delay and regression of tumor growth without changing the natural structure and characterization of DCs in melanoma and breast cancers in vivo. (** The shRNA IDO- DCvax is developed by Regen BioPhrama, San Diego, CA ,  Thomas Ichim, Ph.D, CSO. and David Koos, CEO)"

Current IDO Clinical Trials; short version. Is a matter of time before Regen will be among these listed.

1

Clinical Trials From Clinicaltrials.Gov

Title And Details Of The Study

NCT Number

Recruitment

Condition

Primary Completion Date

Sponsor/Collaborator

Phase or

Observation.

Intervention Type

2

IDO Inhibitor Study For Relapsed Or Refractory Solid Tumors

NCT00739609

Terminated

Breast Cancer|Lung Cancer|Melanoma|Pancreatic Cancer|Solid Tumors

October 2012

NewlLink enetics Corp.

1

CHEM

3

IDO2 Genetic Status Informs The Neoadjuvant Efficacy Of Chloroquine (CQ) In Brain Metastasis Radiotherapy

NCT01727531

Recruiting

Brain Metastasis

Dec. 2020

Main Line Health

NA

CHEM

4

Peptide Vaccine And Temozolomide For Metastatic Melanoma Patients

NCT01543464

Recruiting

Malignant Melanoma

September 2014

Newlink Genetics Corporation

2

CHEM

5

A Phase 1/2 Randomized, Blinded, Placebo Controlled Study Of Ipilimumab In Combination With INCB024360 Or Placebo In Subjects With Unresectable Or Metastatic Melanoma

NCT01604889

Recruiting

Metastatic Melanoma

August 2014

Incyte Corporation

1/2

BIOL

INH+

CHEM

6

A Phase 2 Study Of The IDO Inhibitor INCB024360 Versus Tamoxifen For Subjects With Biochemical-Recurrent-Only EOC, PPC Or FTC Following Complete Remission With First-Line Chemotherapy

NCT01685255

Recruiting

April 2014

Incyte Corporation

2

CHEM

7

Different Injection Number Of The Same Dose Of Botulinum Toxin A On Overactive Bladder Syndrome

NCT01657409

Recruiting

Overactive Bladder

March 2014

Buddhist Tzu Chi General Hospital

2

CHEM

8

Study On The Effect Of Intravenous Ascorbic Acid On Intraoperative Blood Loss In Women With Uterine Myoma

Interventions: Drug: Ascorbic Acid

NCT01715597

Recruiting

Uterine Leiomyoma

January 2014

Seoul National University Hospital

3

CHEM

9

1-Methyl-D-Tryptophan In Treating Patients With Metastatic Or Refractory Solid Tumors That Cannot Be Removed By Surgery

NCT00567931

Recruiting

Unspecified Adult Solid Tumor, Protocol Specific

September 2013

National Cancer Institute (NCI)

1

CHEM

10

Properties Of Mesenchymal Stem Cells In Lung Transplant

NCT01668576

Recruiting

Lung Transplantation

August 2013

Emory University

OBS

BIOL

11

The Effects Of Medical Clowns In Children Undergoing Blood Tests

NCT01396876

Recruiting

Pain And Anxiety Reduction

July 2012

Tel-Aviv Sourasky Medical Center

NA

BIOL

12

Saline Injection - Assisted Anesthesia In Eyelid Surgery

NCT01239498

Recruiting

Blepharoptosis

October 2011

Sheba Medical Center

4

CHEM

BIOL

13

Effects Of The Consumption Of California Walnuts On Cardiovascular Health

Interventions:            Dietary Supplement: Walnuts

NCT01235390

Recruiting

Cardiovascular Disease|Immune Health

October 2011

University Of California, Davis|California Walnut Commission

1

FOOD

ALERGY-WALNUT

14

Pomegranate To Reduce Maternal And Fetal Oxidative Stress And Improve Outcome In Pregnancies Complicated With Preterm Premature Rupture Of The Membranes

NCT01584323

Recruiting

Preterm Premature Rupture Of Membranes|Pregnant State

2013

Rambam Health Care Campus

NA

FOOD

SUP

1

Phase II INCB024360 Study For Patients With Myelodysplastic Syndromes (MDS)

NCT01822691

Not Yet Recruiting

Myelodysplastic Syndromes

September 2015

H. Lee Moffitt Cancer Center And Research Institute|Incyte Corporation

2

CHEM-BIOL?

2

Title:  Schizophrenia Imaging

NCT01655472

Not Yet Recruiting

Foetal Differences Between Healthy And Schizophernic Parents

July 2014

Tel-Aviv Sourasky Medical Center

IMAGE

N

3

C11 AMT Positron Emission Tomography (PET) Imaging In Patients With Metastatic Invasive Breast Cancer

NCT01302821

Not Yet Recruiting

Breast Cancer

April 2014

H. Lee Moffitt Cancer Center And Research Institute|National Cancer Institute (NCI)

NA

BIOL

DC

AV-P53

MT

RADIA

4

Sonographic Evaluation Of Visceral Fat After Bariatric Surgery

NCT01285791

Not Yet Recruiting

Morbid Obesity

April 2012

Hadassah Medical Organization

OBS

BIOL CELL

5

How Our Immune System Can Help Fight Cancer

NCT01042847

Not Yet Recruiting

Ovarian Cancer

January 2011

Winthrop University

Hospita

EVAL

NA

POLY.

BIOL

6

Title: Study Of The Long-Term Effect Of Frequent Anti-VEGF Dosing On Retinal Function In Patients With Neovascular AMD

NCT00533689

Not Yet Recruiting

Electrophysiology

2013 NA

Tel-Aviv Sourasky Medical Center

NA

EYE

BIOL

7

Microbial Surveillance In Children Hospitalized For Cardiovascular Surgery

NCT00426894

Not Yet Recruiting

Cardiac Surgery|Perioperative Prophylaxis

2013 NA

Hadassah Medical Organization

OBS

8

Study Of Chemotherapy In Combination With IDO Inhibitor In Metastatic Breast Cancer

NCT01792050

Not Recruitinbut  Active  G

Metastatic Breast Cancer

January 2015

Newlink Genetics Corporation

2

CHEM

9

A Dose-Escalation Study In Subjects With Advanced Malignancies

NCT01195311

Not BUT  Active Recruiting

Advanced Malignancies

November 2012

Incyte Corporation

1

CHEM DOSE

SP

Title:   Mesalamine To Reduce T Cell Activation In HIV Infection

NCT01090102

Enrolling By Invitation

HIV Infections|Sexually Transmitted Diseases|Immune System Diseases|Lentivirus Infections|Acquired Immunodeficiency Syndrome

January 2013

UC, San Francisco|California HIV/AIDS Research Program|Salix Pharmaceuticals

4

CHEM

1

Study Of Indoleamine 2,3-Dioxygenase Activity, Serum Levels Of Cytokines, BDNF, BH4 And

NCT00919295

Completed

Fibromyalgia Syndrome

October 2011

Mahidol University|University Of Texas|University Of Wuerzburg

2

CHEM.

2

Diagnosis Of Posttraumatic Stress Disorder Following Primary Rhegmatogenous Retinal Detachment

NCT01233908

Completed

Stress Disorders, Post-Traumatic|Retinal Detachment

September 2010

Sheba Medical Center

OBS

EYE

BIOL

3

Comparison Of DCT, ORA And GAT In Eyes After Penetrating Keratoplasty

NCT00834782

Completed

Corneal Transplantation

December 2009

Sheba Medical Center

4

4

Disturbances Of Kynurenine Pathway Of Trytophan Metabolism In Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study

NCT00573300

Completed

Schizophrenia

May 2009

North Suffolk Mental Health Association

OBSV.

BIOL

5

Effect Of Biological Therapy On Biomarkers In Patients With Untreated Hepatitis C, Metastatic Melanoma, Or Crohn Disease

NCT00897312

Completed

Melanoma

August 2008

Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI)

OBSV.

BIOL-CHEM

6

A Prospective Comparative Study Of Induction Of Labor With A Cervical Ripening Double Balloon Vs Foley Catheter

NCT00501033

Completed

Induction Of Labor|Cesarean|Endometritis

February 2008

Western Galilee Hospital-Nahariya

NA

DEVICE

7

Tryptophan, Serotonin And Kynurenine In Septic Shock

NCT00684736

Completed

Shock, Septic

April 2007

Central Hospital, Versailles

OBS

KYN

8

Imatinib Mesylate In Treating Patients With Metastatic Breast Cancer

NCT00045188

Completed

Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer

July 2004

National Cancer Institute (NCI)

2

CHEM

9

IDO Peptid Vaccination For Stage III-IV Non Small-Cell Lung Cancer Patients.

NCT01219348

Completed

NSCLC|Lung Cancer

NA

IDO Peptide Vaccinantio

1

10

Indoleamine 2,3-Dioxygenase (IDO) Activity In Patients With Chronic Lymphocytic Leukemia (CLL)

NCT01397916

Completed

CLL

NA

Tampere University Hospital

NA

11

Tryptophan Metabolism In Kidney Disease

NCT00758537

Completed

Chronic Kidney Disease

NA

Charite University, Berlin, Germany

OBS

BIOL

TRP LEVELS

12

Observational To Investigate The Efficacy Of CRESTOR 5mg In Reaching LDL-C Target Goals In Patients Who Are At High Risk For A Cardiovascular Event

NCT00347217

Completed

Hypercholesteremia

Cardiovascular

NA

Astrazeneca

4

CHEM

13

The Association Between Delivery Method And Maternal Rehospitalization

NCT00501501

Completed

Hospitalization

NA

Western Galilee Hospital-Nahariya

OBS

BIOL

14

Uterine Flora During Elective And Urgent Cesarean Sections

NCT00500019

Completed

Endometritis

NA

Western Galilee Hospital-Nahariya

OBS

BIOL

15

Title: Pilot, Proof-Of-Concept Study Of Sublingual Tizanidine In Children With Chronic Traumatic Brain Injury (TBI)

NCT00287157

Completed

Traumatic Brain Injury

NA

Teva GTC

1

B

CHEM

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 108

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 109

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 109

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 97

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading

Top 5 Most Recently Viewed Articles

Ready Capital Corporation's 2024 Results Overview & Future Insights

Updated Category News Views 176

Ready Capital Corporation's Upcoming Financial Results Ready Capital Corporation (NASDAQ: RC) is poised to share its financial results for the fourth quarter and the full year of 2024. This significant announcement is expected to take place before the opening bell of the New York Stock Exchange on the designated release date. Investors and interested parties are eagerly...

Continue Reading
Nano-X Faces Securities Suit, Investors Alerted

Updated Category News Views 32

Legal Tsunami Hits Nano-X Imaging If there’s one thing that makes investors' hairs stand on end, it’s the words 'class action lawsuit.' And now, it's swirling around Nano-X Imaging Ltd. (NASDAQ: NNOX) like a tempest. The DJS Law Group has taken the lead, lighting the legal torches on claims that Nano-X fed investors a cocktail of misleading statements regarding its...

Continue Reading
Novo Nordisk A/S Shareholders: Take Action on Recent Allegations

Updated Category News Views 218

Understanding the Novo Nordisk A/S Class Action Opportunity Recent developments have led to significant scrutiny of Novo Nordisk A/S, a major player in the pharmaceutical industry. For shareholders, this highlights a crucial opportunity to engage in a class action lawsuit regarding alleged misleading statements about the company's CagriSema weight loss study results....

Continue Reading
Investors of Inspire Medical Systems Should Act Before Deadline

Updated Category News Views 288

Important Deadline for Inspire Medical Systems Investors Investors of Inspire Medical Systems, Inc. are reminded that a critical deadline is approaching for those who purchased securities. The firm Kirby McInerney LLP has encouraged investors to take action as they seek the lead plaintiff role in a federal securities class action. About the Legal Proceedings This lawsuit...

Continue Reading
Nicholas Wealth's Impressive $GIAX Distribution Yield Announcement

Updated Category News Views 88

Recent Announcement from Nicholas Wealth Management Nicholas Wealth, renowned for its commitment to delivering actively managed income ETFs, has made an exciting announcement regarding its latest distribution. The Nicholas Global Equity and Income ETF (GIAX) will offer investors a substantial monthly distribution yield of an impressive 24.00%. This announcement is...

Continue Reading